Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: Graham Marshman who wrote (104)	12/1/1997 5:36:00 PM
From: MarcG	Respond to of 857

Graham and All, <<just a question of when>> Please confer: cfids.org And for specific dates and treatment durations: cfids.org Please note in the Chronicle that initially 5 doctors had been approved for the IND treatment program and that 6 more had applied for participation, while many more had expressed their interest. If and when the news is positive, I believe the sequence of events will an expansion of the trial announced by FDA approval and the inclusion of many more doctors and patients. Kind regards, Marc